Total Neoadjuvant Therapy With Long-Course Radiotherapy Studied in High-Risk Rectal Cancer

◆ TRIAL DATA

The multicenter phase III TNTCRT trial compared total neoadjuvant therapy using long-course radiotherapy versus chemoradiotherapy in patients with high-risk locally advanced rectal cancer. (Journal of Clinical Oncology)